Tatiana Terrot

597 total citations
5 papers, 129 citations indexed

About

Tatiana Terrot is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Tatiana Terrot has authored 5 papers receiving a total of 129 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Tatiana Terrot's work include Chronic Lymphocytic Leukemia Research (2 papers), Cancer Treatment and Pharmacology (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Tatiana Terrot is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Cancer Treatment and Pharmacology (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Tatiana Terrot collaborates with scholars based in Switzerland, Italy and Australia. Tatiana Terrot's co-authors include Mathilde Foglierini, Christian Garzoni, Federica Sallusto, Laurent Perez, Antonio Lanzavecchia, Jun Siong Low, Antonino Cassotta, Paolo Ferrari, Josipa Jerak and Federico Mele and has published in prestigious journals such as Science, Blood and Clinical Cancer Research.

In The Last Decade

Tatiana Terrot

5 papers receiving 125 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tatiana Terrot Switzerland	4	79	51	34	24	15	5	129
Eva‐Maria Jacobsen Germany	7	45 0.6×	46 0.9×	67 2.0×	9 0.4×	9 0.6×	17	141
Tatjana Bilich Germany	6	100 1.3×	58 1.1×	56 1.6×	33 1.4×	28 1.9×	10	153
Renato Gammaldi Italy	3	61 0.8×	20 0.4×	26 0.8×	11 0.5×	27 1.8×	8	96
Jens Bauer Germany	7	94 1.2×	88 1.7×	93 2.7×	49 2.0×	25 1.7×	19	208
Michael J. Pitcher United Kingdom	8	36 0.5×	76 1.5×	82 2.4×	16 0.7×	9 0.6×	11	194
Thure Mors Haunstrup Denmark	5	72 0.9×	11 0.2×	23 0.7×	12 0.5×	14 0.9×	15	131
Lorien Shakib United States	2	54 0.7×	64 1.3×	67 2.0×	13 0.5×	33 2.2×	4	163
Dai Keino Japan	7	17 0.2×	38 0.7×	13 0.4×	30 1.3×	9 0.6×	35	117
Selina J Chavda United Kingdom	5	39 0.5×	38 0.7×	33 1.0×	98 4.1×	6 0.4×	12	135
Joanna Jarkiewicz‐Tretyn Poland	6	69 0.9×	33 0.6×	11 0.3×	16 0.7×	5 0.3×	12	137

Countries citing papers authored by Tatiana Terrot

Since Specialization

Citations

This map shows the geographic impact of Tatiana Terrot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatiana Terrot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatiana Terrot more than expected).

Fields of papers citing papers by Tatiana Terrot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tatiana Terrot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatiana Terrot. The network helps show where Tatiana Terrot may publish in the future.

Co-authorship network of co-authors of Tatiana Terrot

This figure shows the co-authorship network connecting the top 25 collaborators of Tatiana Terrot. A scholar is included among the top collaborators of Tatiana Terrot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tatiana Terrot. Tatiana Terrot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Colombo, Ilaria, Sofia Genta, Federica Martorana, et al.. (2021). Phase I Dose-Escalation Study of the Dual PI3K-mTORC1/2 Inhibitor Gedatolisib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid Tumors. Clinical Cancer Research. 27(18). 5012–5019. 27 indexed citations

2.

Low, Jun Siong, Federico Mele, Mathilde Foglierini, et al.. (2021). Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2. Science. 372(6548). 1336–1341. 85 indexed citations

3.

Pirosa, Maria Cristina, Lu Zhang, Felicitas Hitz, et al.. (2021). A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomas. Leukemia & lymphoma. 63(1). 117–123. 7 indexed citations

4.

Colombo, Ilaria, Sofia Genta, Federica Martorana, et al.. (2020). 568P Phase I dose-escalation study of the dual PI3K/mTORC1/2 inhibitor Gedatolisib (PF-05212384) in combination with paclitaxel (P) and carboplatin (C) in patients (pts) with advanced solid tumours. Annals of Oncology. 31. S487–S487. 3 indexed citations

5.

Ghielmini, Michele, Laura Negretti, Erika Lerch, et al.. (2005). Infusion Speed-Escalation Trial To Give Full-Dose Rituximab in One Hour without Steroids Pre-Medication.. Blood. 106(11). 2451–2451. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact